Stock listing

CHM Stock Price, News, Filings & Events — Chimeric Therapeutics Limited

Selected listing: CHM · ASX · AUD · AU

This page tracks Chimeric Therapeutics Limited's CHM:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CHM:ASX. CHM:ASX is the stock-level entry point for investors researching Chimeric Therapeutics Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Chimeric Therapeutics Limited (Ticker: CHM) is a public company listed on the Australian market, with a market capitalization of approximately AUD 1.94 million. The company focuses on developing innovative therapies in the field of cell and gene therapy. Chimeric Therapeutics aims to address significant unmet medical needs through its advanced research and development initiatives.